Jeroen S. Goede

Winterthur, ZH 8401, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

Treatment of multiple sclerosis with peptide-coupled red blood cells induces antigen-specific T regulatory cells.

Treatment of multiple sclerosis with peptide-coupled red blood cells induces antigen-specific T regulatory cells.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: August 31, 2026

A Cold Case Solved

A Cold Case Solved

Journal: Praxis

Published: April 20, 2026

Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia.

Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia.

Journal: The New England journal of medicine

Published: December 08, 2025

Prognostic Impact of the AML60+ Score for Elderly Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents: A Retrospective Multicentric Analysis.

Prognostic Impact of the AML60+ Score for Elderly Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents: A Retrospective Multicentric Analysis.

Journal: Cancers

Published: June 29, 2025

Rational use of immunoglobulins (IVIgs and SCIgs) in secondary antibody deficiencies.

Rational use of immunoglobulins (IVIgs and SCIgs) in secondary antibody deficiencies.

Journal: Swiss medical weekly

Published: October 27, 2024

Role of Piezo1 in Terminal Density Reversal of Red Blood Cells.

Role of Piezo1 in Terminal Density Reversal of Red Blood Cells.

Journal: Cells

Published: July 19, 2024

Panhypopituitarism, Diabetes Insipidus and Bone Pain - Is There a Systemic Disease Behind it?

Panhypopituitarism, Diabetes Insipidus and Bone Pain - Is There a Systemic Disease Behind it?

Journal: Praxis

Published: February 21, 2024

High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations.

High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations.

Journal: Blood

Published: January 17, 2023

Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial.

Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial.

Journal: Leukemia

Published: September 12, 2022

Hemoglobin is an oxygen-dependent glutathione buffer adapting the intracellular reduced glutathione levels to oxygen availability.

Hemoglobin is an oxygen-dependent glutathione buffer adapting the intracellular reduced glutathione levels to oxygen availability.

Journal: Redox biology

Published: September 05, 2022

Feasibility of electronic patient-reported outcome monitoring and self-management program in aplastic anemia and paroxysmal nocturnal hemoglobinuria-a pilot study (ePRO-AA-PNH).

Feasibility of electronic patient-reported outcome monitoring and self-management program in aplastic anemia and paroxysmal nocturnal hemoglobinuria-a pilot study (ePRO-AA-PNH).

Journal: Annals of hematology

Published: May 24, 2022

Acquired Stomatocytosis in Hyperosmolar Hyperglycemic Derangement

Acquired Stomatocytosis in Hyperosmolar Hyperglycemic Derangement

Journal: Praxis

Published: April 13, 2022

Showing 1-12 of 50

Last Updated: 09/26/2026